SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-067392
Filing Date
2017-11-09
Accepted
2017-11-09 16:21:13
Documents
66
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20648_110q.htm 10-Q 1235691
2 EX-31.1 a17-20648_1ex31d1.htm EX-31.1 11198
3 EX-31.2 a17-20648_1ex31d2.htm EX-31.2 11203
4 EX-32.1 a17-20648_1ex32d1.htm EX-32.1 5018
5 EX-32.2 a17-20648_1ex32d2.htm EX-32.2 5028
  Complete submission text file 0001104659-17-067392.txt   5856051

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20170930.xml EX-101.INS 1436560
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20170930.xsd EX-101.SCH 43242
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20170930_cal.xml EX-101.CAL 49272
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20170930_def.xml EX-101.DEF 137348
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20170930_lab.xml EX-101.LAB 417502
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20170930_pre.xml EX-101.PRE 279422
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 171191134
SIC: 2834 Pharmaceutical Preparations